30 Years After Transition, Cori Cohn Speaks Out (#32)
25 August 2025
With Cori Cohn
North America
Cori Cohn underwent genital surgery at nineteen in 1994 and three decades on describes the outcome as leaving him feeling neither male nor female. Now a US state-level advocate against youth gender medicine, he speaks about inadequate psychological screening, permanent surgical injury and the difficulty of sustaining relationships. His testimony is a rare long-term data point from someone who lived through gender medicine before it became an industry — and it carries direct implications for how Ireland approaches clinical consent, follow-up and safeguarding in its own paediatric gender services.
Cori Cohn was nineteen years old in 1994 when he underwent genital surgery, having started taking oestrogen the previous year at eighteen. He had encountered the concept of transsexualism on afternoon television as a teenager growing up in Reno, Nevada — a sensitive boy who was bullied and felt profoundly alienated from his male peers. Three decades later he describes himself as feeling subhuman, existing in a state that is neither male nor female, and he has channelled that experience into sustained legislative advocacy against the medical transitioning of young people. A striking thread in his account is the process by which he obtained approval for irreversible surgery. He consulted two psychologists who declined to recommend him before finding a third who agreed. The episode does not present this as exceptional but as a foreseeable consequence of a system in which a determined young person could persist until they found clinical sign-off. This raises pointed questions about what meaningful gatekeeping looks like — questions that have acquired renewed urgency following the Cass Review's 2024 conclusion that evidence standards across paediatric gender medicine have long been inadequate. The physical consequences Cohn describes are lasting. He speaks of a surgical injury that permanently affects his capacity for physical intimacy and links this directly to an impaired ability to sustain relationships over time. His account is not one of victimhood directed at others; he is clear that he pursued the surgery and wanted it. But he is equally clear that a nineteen-year-old in significant psychological distress was not well served by a process that cleared him for an irreversible procedure within a short period and with minimal sustained assessment. Since 2022, Cohn has testified before state legislatures across the United States, contributing to legislation restricting puberty blockers, cross-sex hormones and surgeries for minors in more than two dozen states. He co-hosts the podcast Informed Dissent and will address a Genspect conference in Albuquerque. In the conversation he also discusses the role of religious institutions — describing the Episcopal Church's framing of support for paediatric gender medicine as a matter of spiritual duty — and reflects on what he observes about the longer-term trajectories of young males who have transitioned. For Ireland, the relevance is concrete. The HSE's paediatric gender service, delivered through Children's Health Ireland, operates under clinical protocols that have been under scrutiny since the Cass findings were published. The broader questions — how Ireland ensures robust psychological assessment before any medical pathway is approved, how long-term follow-up is structured, and whether adequate space exists for young people to reconsider — are not yet resolved. Cohn's testimony spans thirty years and covers the full arc from distressed adolescent to surgical patient to long-term detransitioner and advocate. That kind of longitudinal account is precisely what clinical guidelines need to grapple with, and what Irish policymakers, clinicians and parents deserve to hear.
